Cargando…
Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports
One of the most powerful weapons against COVID-19 is vaccines. After the worldwide spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also in children and adolescents aged 12–18. Since then, alarming reports of cases of myocarditis and/or pericarditis have been not...
Autores principales: | Piras, Alessandra, Melis, Giada, Cugusi, Lucia, Bassareo, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589994/ https://www.ncbi.nlm.nih.gov/pubmed/36278552 http://dx.doi.org/10.3390/pediatric14040048 |
Ejemplares similares
-
A case of myopericarditis following administration of the Pfizer COVID-19 vaccine
por: Morton, Zoey, et al.
Publicado: (2022) -
Covid-19-vaccine-pfizer-biontech: Myopericarditis: 25 case reports
Publicado: (2021) -
Covid-19-vaccine-pfizer-biontech: Acute myopericarditis: 2 case reports
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Myopericarditis: 13 case reports
Publicado: (2022) -
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021)